Futura Medical plc

LSE FUM.L

Futura Medical plc Net Cash Used Provided By Financing Activities for the year ending December 31, 2023: USD 5.79 M

Futura Medical plc Net Cash Used Provided By Financing Activities is USD 5.79 M for the year ending December 31, 2023, a 2,724.50% change year over year. Net cash used/provided by financing activities are the total cash inflows and outflows related to activities that finance the company’s operations, including debt, equity, and dividends.

Futura Medical plc Net Cash Used Provided By Financing Activities for the year ending December 31, 2022 was USD 204.95 K, a -98.89% change year over year.
Futura Medical plc Net Cash Used Provided By Financing Activities for the year ending December 31, 2021 was USD 18.47 M, a 342.09% change year over year.
Futura Medical plc Net Cash Used Provided By Financing Activities for the year ending December 31, 2020 was USD 4.18 M, a 16,248.30% change year over year.
Futura Medical plc Net Cash Used Provided By Financing Activities for the year ending December 31, 2019 was USD 25.55 K, a -99.63% change year over year.

Key data

Date	Net Cash Used Provided By Financing Activities	Dividends Paid	Capital Expenditure	Effect Of Forex Changes On Cash

LSE: FUM.L

Futura Medical plc

CEO	Mr. James Henry Barder
IPO Date	July 22, 2003
Location	United Kingdom
Headquarters	Surrey Technology Centre
Employees	12
Sector	Healthcare
Industries Pharmaceuticals Biotechnology Cosmetics Drugstores & Retail Pharmacies Eyewear Personal Care

Description

Futura Medical plc, a pharmaceutical company, develops pharmaceutical and healthcare products for the consumer healthcare markets focusing on sexual health and pain relief management. Its lead product is MED3000, a topical gel for the treatment of erectile dysfunction. The company also develops pain relief products, including TPR100, a topical diclofenac pain relief gel; CBD100, a topical cannabidiol formulation; and TIB200, a topical ibuprofen pain relief gel. The company was incorporated in 2001 and is headquartered in Guildford, the United Kingdom.

Key trends

Past 5 years